内容
Search
condition:
clear condition

Defects in auxiliary fuel oxidation and mitochondrial pyruvate transport mark transition to overt heart failure in Tgαq*44 mice

Olkowicz M, Jedrzejewska A, Tyrankiewicz U, Fedak FA, Berkowicz P, Kwiatkowski G, Rosales-Solano H, Roy KS, Karas A, Krol O, Tomczyk M, Smolenski RT, Pawliszyn J, Chlopicki S. Defects in auxiliary fuel oxidation and mitochondrial pyruvate transport mark transition to overt heart failure in Tgαq*44 mice. J Transl Med. 2026 Mar 3;24(1):485.

Mouse

Cardiovascular diseases

2026

Exercise mitigates IL-27-induced muscle atrophy following myocardial infarction through anti-inflammatory mechanisms

Li Y, Yin G, Li S, Zheng Q, Jiang Y, Li C, Yang L, Li H, Chen X, Yang P, Sun L. Exercise mitigates IL-27-induced muscle atrophy following myocardial infarction through anti-inflammatory mechanisms. J Transl Med. 2026 Jan 24;24(1):271.

Rat

Cardiovascular diseases

2026

NAT10-Mediated ac4C-Modification Exacerbates Ferroptosis by Stabilizing HMOX1 in Deep Vein Thrombosis

Zhang Y, Zhang Z, Liu X, Chu C, Yu X, Han Q, Li W, Zhang T, Zu H, Fan N, Wei R, Shi F, Li F, Xu F, Wang B, Li X. NAT10-Mediated ac4C-Modification Exacerbates Ferroptosis by Stabilizing HMOX1 in Deep Vein Thrombosis. Arterioscler Thromb Vasc Biol. 2026 Feb;46(2):e323986.

Mouse

BV

2025

Tetrahedral DNA Nanostructures as a Multifactorial Nanotherapeutic Platform for Deep Vein Thrombosis: Targeting Necroptosis, Oxidative Stress, and Inflammation

Li Y, Cao W, Lv Y, Yang H, Xu L, Lu Y. Tetrahedral DNA Nanostructures as a Multifactorial Nanotherapeutic Platform for Deep Vein Thrombosis: Targeting Necroptosis, Oxidative Stress, and Inflammation. Int J Nanomedicine. 2025 Nov 18;20:13837-13855.

Mouse

BV

2025

Theogallin Protects Myocardial Ischemia-Reperfusion Injury by Inhibiting the Interleukin-17 Signaling Pathway

Zhu F, Cheng H, Luo Z, Cao A, Yu T, Ge H, Hu S, Xie Z, Li D. Theogallin Protects Myocardial Ischemia-Reperfusion Injury by Inhibiting the Interleukin-17 Signaling Pathway. J Agric Food Chem. 2025 Aug 6;73(31):19373-19385.

Rat

Cardiovascular diseases

2025

Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury

Ma XR, Yan TM, Pan Y, Jiang ZH. Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury. Mol Ther Nucleic Acids. 2025 Oct 18;36(4):102747.

Rat

Cardiovascular diseases

2025

< 1...333435...45 >

Obtain A Quotation

Submit